- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03263728
Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot Study (CATCH)
August 16, 2019 updated by: The University of Hong Kong
The aim of this study is to determine the prevalence of myocardial ischaemia in asymptomatic high risk type 2 diabetic patients using stress cardiac MR and how many stress cardiac MR examinations are false positive.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Asymptomatic coronary artery disease (CAD) is highly prevalent (ie.
17-59%) in type 2 diabetic patients.
In addition, cardiovascular disease remains the most common cause of death in type 2 diabetics.
Previous trials using coronary computed tomography angiograms (CCTA) or nuclear myocardial perfusion imaging (MPI) to screen for asymptomatic coronary artery disease requiring intervention have been unsuccessful at reducing cardiovascular and all cause mortality when compared to optimised medical therapy where cardiovascular risk factors are treated in order to reduce cardiovascular complications.
Possible reasons for this include, the choice of imaging modality, the intervention chosen (eg.
bare metal stents vs drug eluting stents), patient cohort (eg.
all diabetics vs high risk diabetics).
Stress cardiac magnetic resonance (CMR) is ideally suited to assess this group of high risk patients as there is no radiation exposure and it allows a more complete analysis of the heart including the assessment of myocardial viability, cardiac systolic and diastolic function.
The significance of this envisioned randomised controlled trial is firstly to investigate if stress CMR screening will reduce major adverse cardiovascular events including death.
Secondly, a study using stress CMR has never been performed.
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong
- The University of Hong Kong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Onset of type 2 diabetes at ≥30yrs old with no history of ketoacidosis
- 60-80yrs old
- Framingham Risk Score ≥20%
Exclusion Criteria:
- Angina pectoris or chest discomfort
- Stress test or coronary angiography within 2 years
- Previous myocardial infarction (MI)
- Previous coronary artery stenting or coronary artery bypass grafting
- Any clinical indication or contraindication for stress testing
- Any contraindication to stress CMR (eg. non-MRI compatible devices)
- Contraindication to gadolinium based contrast agent (eg. Renal impairment with an estimated glomerular filtration rate (GFR) <30ml/min/1.73m2)
- Life expectancy <2 years due to cancer or liver disease
- Contraindication to dual antiplatelet therapy
- Planned need for concomitant cardiac surgery
- Refusal or inability to sign an informed consent.
- Potential for non-compliance towards the requirements in the trial protocol
- Unable to cover the costs of percutaneous coronary intervention (PCI) whether through government subsidies, etc
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Stress Cardiac MR
|
Screening of asymptomatic of high risk type 2 diabetic mellitus patients with stress cardiac magnetic resonance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of myocardial ischaemia
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of myocardial infarction
Time Frame: 1 year
|
1 year
|
Clinical predictors of silent ischaemia
Time Frame: 1 year
|
1 year
|
Major adverse cardiovascular events
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 10, 2017
Primary Completion (ACTUAL)
January 29, 2019
Study Completion (ACTUAL)
January 29, 2019
Study Registration Dates
First Submitted
August 24, 2017
First Submitted That Met QC Criteria
August 24, 2017
First Posted (ACTUAL)
August 28, 2017
Study Record Updates
Last Update Posted (ACTUAL)
August 20, 2019
Last Update Submitted That Met QC Criteria
August 16, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UW-17-168
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationKorea, Republic of
Clinical Trials on Cardiac Magnetic Resonance
-
Alejandro Rodriguez Oviedo , MDTerminatedMyocardial Ischemia | Pneumonia, PneumococcalSpain
-
IRCCS San RaffaeleCompletedLeft Ventricular Diastolic DysfunctionItaly
-
Assiut UniversityActive, not recruiting
-
Antonio EspositoMinistry of Health, ItalyUnknownMyocardial Inflammation | Myocarditis AcuteItaly
-
The Cleveland ClinicNational Heart, Lung, and Blood Institute (NHLBI)RecruitingFunctional Mitral Regurgitation | Nonischemic Congestive CardiomyopathyUnited States
-
University Hospital, BonnRecruitingEpilepsy | CardiomyopathiesGermany
-
University Hospital, BonnRecruitingCardiomyopathies | Hypertension, PortalGermany
-
Assiut UniversityNot yet recruiting
-
Semmelweis University Heart and Vascular CenterNational Research, Development and Innovation Fund of Hungary, Project no...RecruitingMagnetic Resonance Imaging | Heart Transplant Failure and RejectionHungary
-
Samsung Medical CenterRainMed Medical; Shanghai Institute of Cardiovascular DiseasesActive, not recruitingST-segment Elevation Myocardial Infarction (STEMI)United States, China